When to start PCT after the last shot?

Timing depends on ester. For testosterone propionate (half-life ~2 d): start W+3 to W+5 days after last injection. For Sustanon mix or ester blend: W+10-14 days. For testosterone enanthate/cypionate (half-life ~4-5 d): W+14-18 days. For nandrolone decanoate (half-life ~6-12 d depending on source): W+3 wk minimum. General rule: wait about 3 half-lives for serum concentration to fall below the hypothalamic negative-feedback threshold (Schulte-Beerbühl 1980, Toutain 2004). Starting too early = SERM against still-elevated serum concentration = ineffective.

Is hCG always needed in PCT?

No, depends on the cycle. For short/light cycles (Test E solo 12 wk), Nolvadex alone suffices. For long cycles (>16 wk), heavy stacks (Test + Deca/Tren), or users with laborious HPG recovery on prior cycles: pre-PCT hCG (1500-2000 IU E2D for 10 d) significantly improves recovery (Coviello 2005, Wenker 2015). hCG 'wakes up' Leydig cells before SERM start. Alternative: on-cycle hCG (250-500 IU 2x/wk from W2) to preserve testicular volume during cycle (Coviello 2005 RCT).

How long to recover natural testosterone levels?

Variable depending on several factors: cycle duration, molecules used, age, HPG genetics. Smit 2021 (HAARLEM cohort, 100 Dutch users) documents average recovery in 12-16 weeks post-PCT for moderate cycles (15 wk average), with ~70% of users returning to >85% baseline at 6 months. Long cycles with nandrolone or trenbolone: recovery often 6-9 months. Beyond 6 months without recovery = probable ASIH, endocrinologist consultation recommended (Rahnema 2014, Kanayama 2015).

What bloodwork during and after PCT?

Mid-PCT bloodwork (W+2 wk of PCT): not essential but useful if in doubt. Post-PCT bloodwork (4-6 wk after PCT end): crucial. Measure LH, FSH, total and free testosterone, ultra-sensitive E2, prolactin, SHBG. Target values at 6 wk post-PCT: LH in normal range (1.5-9 IU/L), normal FSH (1.5-12 IU/L), total testosterone >450 ng/dL ideally (norm 250-1000). If low LH and low T: incomplete recovery, wait 6 more wk then re-test. If still low at 3 months: endocrinologist consultation. Source: Anawalt 2019, Pope 2014.

Nolvadex or Clomid: which to choose?

Nolvadex (tamoxifen): better tolerance, fewer visual and mood effects, suffices for short/moderate cycles. Clomid (clomiphene): more marked HPG stimulation via GnRH effect, useful for heavier cycles, but more frequent side effects (visual disturbances per Purvin 1995, irritability, anxiety). In practice: Nolva solo for first PCT; Nolva + Clomid combo for moderate-to-heavy cycles. If known Clomid sensitivity (prior visual disturbances), switch to enclomiphene or Nolva solo dosed slightly longer.

What to do if HPG recovery fails after a well-conducted PCT?

Algorithm: (1) Confirm failure with repeat bloodwork at 3 months post-PCT (low LH + low T). (2) Eliminate confounders (vitamin D deficiency, hyperthyroidism, obesity, medications). (3) Attempt repeat PCT with pre-PCT hCG + Clomid 25 mg/d for 8-12 wk (Lipshultz protocol, Rahnema 2014). (4) If failure at 6 cumulative months: ASIH diagnosis, urologist/endocrinologist consultation. (5) Options: long-term Clomid continuation (Katz 2012, Ramasamy 2014), or switch to medicalized TRT based on preference and desired fertility. Reference framework: Bhasin 2018 (Endocrine Society Guideline).

Can hCG alone replace a classic PCT?

No. hCG mimics endogenous LH and directly stimulates Leydig cells, but it does not wake up the hypothalamic HPG axis. An hCG-only PCT will leave the user dependent on hCG to produce testosterone, without restoring hypothalamic-pituitary feedback. hCG is useful in pre-PCT (Leydig wake-up) or on-cycle (testicular preservation), but must be followed by a SERM (Nolva/Clomid) which restores GnRH-LH-FSH pulsatility. Liu 2002 (hCG meta-analysis spermatogenesis induction) confirms this logic.

What effects on libido and mood during PCT?

Sensitive period. Exogenous testosterone stops covering the user (progressive ester clearance), while endogenous testosterone is not yet restored — hence 'PCT depression': libido drop, fatigue, anxiety, irritability, sleep disturbances. Transient phenomenon in most (3-8 wk), resolved with natural testosterone restoration. Support strategies: sleep >=8h, maintained moderate exercise, stable nutrition, vitamin D + ZMA supplementation. If mood degraded >12 wk, medical consultation (Piacentino 2015, Kanayama 2009 on AAS dependence and withdrawal symptoms).

Best PCT (post-cycle therapy) protocols in 2026 — 10 schemes ranked

Methodology

Rankings based on 4 weighted criteria. (1) HPG recovery efficacy: percentage of users recovering >85% of baseline testosterone level at 12 wk post-PCT, per HAARLEM data (Smit 2021) and the Rahnema 2014 review. (2) Protocol simplicity: number of molecules, dosing frequency, required monitoring, total cost. (3) Safety profile: SERM tolerance (tamoxifen, clomiphene — Clomid visual effects documented by Purvin 1995), risk of side effects of complex protocols (hCG, parallel AI). (4) Fit with cycle type: a short Test E solo cycle does not require the same PCT as a Test + Deca for 16 wk or as post-blast & cruise. Protocols are graded from simplest to most complex. Primary sources: Rahnema 2014 (ASIH diagnosis and treatment), Coviello 2005 (hCG intratesticular), Liu 2002 (hCG meta), Wenker 2015 (hCG combination), Smit 2021 (HAARLEM testicular recovery), Katz 2012 (clomiphene young hypogonadal men), Whitten 2006.

1. Nolvadex 40/40/20/20 for 4 wk — the standard PCT for short cycles
The reference protocol for short/light cycles (Test E solo 12-14 wk at 400-500 mg/wk, or solo SARMs cycles). Tamoxifen (Nolvadex) blocks hypothalamic estrogen receptors, lifting negative feedback and allowing LH and FSH resumption (Vermeulen 1978, Jordan 1993). Excellent tolerance, few side effects compared to Clomid.
Dose / Duration
Tamoxifen: 40 mg/d for 2 wk, then 20 mg/d for 2 wk. Start: W+2 to W+3 after last injection (for long ester), or W+3 days (short ester). Total duration: 4 wk.
Target audience
First Test E solo 400-500 mg/wk for 12 wk cycles, solo SARMs cycles, users with demonstrated HPG recovery on prior cycles.
Pros
- + Simple, mono-molecule protocol, few side effects
- + Well-documented efficacy (Vermeulen 1978, Jordan 1993)
- + Accessible cost (~$30-50 for complete PCT)
- + Excellent overall tolerance vs Clomid
- + Wide pharmacy and UGL availability
Cons
- − Insufficient for long cycles (>16 wk) or heavy stacks
- − No direct effect on Leydig cells
- − Hot flashes, transient libido drop
- − Risk of ocular effects at very high doses (Purvin 1995: risk on Clomid > Nolvadex)
- − Biphasic effect on IGF-1
2. Nolvadex + Clomid (40/40/20/20 + 50/50/25/25) for 4 wk — the classic medium-cycle PCT
The standard for medium cycles (Test E 500 mg/wk ± oral, 12-14 wk). The Nolvadex + Clomid combo attacks estrogenic negative feedback on two fronts: tamoxifen for hot flashes and residual gynecomastia, clomiphene to more aggressively stimulate hypothalamic GnRH release (Katz 2012, Whitten 2006). Faster HPG recovery according to Rahnema 2014.
Dose / Duration
Tamoxifen: 40 mg/d for 2 wk, then 20 mg/d for 2 wk. Clomiphene: 50 mg/d for 2 wk, then 25 mg/d for 2 wk. Start same timing as Nolva solo. Duration: 4 wk.
Target audience
Medium 12-14 wk cycles with moderate Test E (400-500 mg/wk) ± oral kickstart, users already familiar with PCT, seeking faster HPG recovery.
Pros
- + Synergy of two SERMs on HPG axis
- + Faster HPG recovery vs Nolva solo (Rahnema 2014)
- + Empirically validated by 30 years of use
- + Moderate cost (~$50-80)
- + Good overall tolerance
Cons
- − Clomid side effects: visual disturbances ("flickering"), mood changes (Purvin 1995)
- − Protocol cumbersome (4 doses/d)
- − No direct action on Leydig cells
- − Insufficient for very long cycles or deca/tren stacks
- − Compliance harder than Nolva solo
3. Pre-PCT hCG + Nolvadex + Clomid — the long-cycles/heavy-stacks PCT
Advanced protocol for long cycles (>16 wk) or stacks with deca/tren. Phase 1: hCG 1500-2000 IU E2D for 10 days to 'wake up' Leydig cells after prolonged suppression (Coviello 2005, Wenker 2015). Phase 2: standard Nolvadex + Clomid for 4 wk. hCG mimics endogenous LH and allows testicular steroidogenesis restart before SERM kickoff.
Dose / Duration
Phase 1 hCG: 1500-2000 IU E2D for 10 days (W+3 days post-last short ester injection, W+2 wk post-long ester). Phase 2 SERM: Nolvadex 40/40/20/20 + Clomid 50/50/25/25 for 4 wk, starting 3 days after last hCG injection.
Target audience
Long cycles (>16 wk), stacks with nandrolone decanoate or trenbolone enanthate, advanced users (3rd cycle+), laborious HPG recovery on prior cycles.
Pros
- + Documented testicular wake-up (Coviello 2005, Wenker 2015)
- + Faster and more complete HPG recovery post-long cycles
- + Suited to deep suppressions (deca, tren, prolonged blast)
- + Reduces ASIH risk (Rahnema 2014)
- + Allows restart even after suppression > 4 months
Cons
- − Higher cost (~$100-150 complete PCT)
- − Logistical burden (hCG injections + 4 oral doses/d)
- − Leydig desensitization risk if hCG poorly dosed or prolonged
- − E2 may increase under hCG (mini-aromatization) — AI to titrate
- − Black market: highly variable hCG quality
4. On-cycle hCG + Nolvadex PCT — the "testicular preservation" strategy
Preventive strategy: maintain an LH-like signal during the cycle via low-dose hCG (250-500 IU 2x/wk), to preserve testicular volume and Leydig function. Coviello 2005 (RCT) demonstrates that 250 IU hCG E2D maintains intratesticular testosterone at -7% vs -57% under testosterone alone. Allows simpler post-cycle PCT (Nolvadex alone suffices).
Dose / Duration
On-cycle: hCG 250-500 IU 2x/wk (from W2 of cycle). hCG stop: 1-2 wk before cycle end. PCT: Nolvadex 40/40/20/20 for 4 wk, start W+2-3 post-last injection.
Target audience
Users having done prior cycles with slow HPG recovery, users on long or repeated cycles, seeking preserved long-term fertility.
Pros
- + Testicular volume preserved during cycle
- + Simplified post-cycle PCT (Nolva solo suffices)
- + Faster HPG recovery
- + Psychological comfort (visibly non-atrophied testicles)
- + Solid scientific reference (Coviello 2005)
Cons
- − hCG engagement throughout entire cycle duration
- − Additional cost during cycle
- − If hCG too high: Leydig desensitization + E2 increase
- − Logistics of additional injections
- − Black market: variable hCG quality (Magnolini 2022)
5. Clomid solo 50/50/25/25 for 4 wk — the SARMs/light-cycles PCT
Minimalist PCT for SARMs cycles (Ostarine, light RAD140) or very light AAS cycles (short solo Test E 300 mg/wk). Clomid at 50 mg/d for 2 wk then 25 mg/d for 2 wk strongly stimulates GnRH release. Studies in young hypogonadal men (Katz 2012, Whitten 2006) document effective elevation of LH/FSH and testosterone.
Dose / Duration
Clomiphene: 50 mg/d for 2 wk, then 25 mg/d for 2 wk. Variable start depending on ester or SARM type. Duration: 4 wk.
Target audience
SARMs cycles (Ostarine 25 mg/d for 8 wk, RAD140 10 mg/d for 8 wk), very light AAS cycles (Test E 300 mg/wk for 8-10 wk), first PCT experiences.
Pros
- + Marked HPG stimulation via GnRH effect
- + Documented efficacy in hypogonadal men (Katz 2012)
- + Very accessible cost (~$20-40)
- + Sufficient for light cycles
- + Wide availability (pharmacy and UGL)
Cons
- − Visual effects (Purvin 1995: "flickering", blurred vision) in 5-10% of users
- − Mood changes (irritability, anxiety)
- − Insufficient for moderate/heavy AAS cycles
- − No direct action on Leydig cells
- − Pro-estrogenic effect long term at high doses
6. Medicalized "Lipshultz" PCT — the supervised restart
Protocol inspired by American urological literature (Lipshultz, Crosnoe, Kovac, Kim) for users who failed a classic PCT or present with ASIH (anabolic steroid-induced hypogonadism). Combines hCG, low-dose long-term Clomid, sometimes pure enclomiphene, and monthly biological monitoring for 6 months. Rahnema 2014 and Crosnoe 2013 document this scheme.
Dose / Duration
hCG 1500 IU 2x/wk for 4 wk, then Clomid 25 mg/d continuous for 12-24 wk with monthly LH/FSH/T monitoring. Adaptations based on response. Endocrinologist/urologist supervision.
Target audience
Users with confirmed ASIH (testosterone <250 ng/dL + low LH 3 months post-classic PCT), willingness for natural recovery vs TRT, available medical access.
Pros
- + Medical supervision guarantees individual case adaptation
- + Validated by urological literature (Rahnema 2014, Crosnoe 2013)
- + Alternative to TRT in young ASIH user
- + Continuous monitoring allows precise adjustments
- + Allows HPG recovery in difficult cases
Cons
- − High cost (consultations + bloodwork + medication ~$600-1000)
- − Long commitment (6-24 months)
- − Medical access not always simple
- − Clomid side effects long term
- − Not suited to standard post-cycle PCT
7. Blast & cruise "PCT" — transition to permanent TRT
No longer a PCT in the strict sense, but an alternative strategy for multi-cycle users who have exhausted natural recovery options. Switch to medically supervised TRT at physiological dose (testosterone 100-150 mg/wk) with maintenance hCG (500 IU 2x/wk). Bhasin 2018 (Endocrine Society Guideline) frames TRT indications. Bridging between cycles, no more classic PCT.
Dose / Duration
Cruise: Testosterone enanthate 100-150 mg/wk continuous + hCG 500 IU 2x/wk. Bloodwork every 3 months (total/free T, E2, hematocrit, lipids, PSA). Periodic blast 500 mg/wk for 8-12 wk.
Target audience
Users having done 6+ cycles, established ASIH, informed choice of permanent TRT, short-term fertility not prioritized, accessible medical supervision.
Pros
- + Avoids stop-restart cycles and cumulative ASIH risk
- + Hormonal and psychological stability
- + Medical supervision possible (legal TRT)
- + Maintenance of muscle gains between blasts
- + Bhasin 2018 frames medical indications
Cons
- − Permanent dependence on exogenous testosterone
- − Non-negligible annual cost (~$500-1500 depending on supervision)
- − Reduced fertility (mitigated by hCG)
- − Long-term cardiovascular effect to monitor (Lincoff 2023 TRAVERSE)
- − Not suitable if immediate fertility desired
8. SARMs "PCT" — restart with Ostarine in transition
Controversial strategy: use a low-dose SARM (Ostarine 12.5 mg/d) in post-cycle transition to preserve muscle mass during HPG recovery under SERM. Ostarine is less suppressive than AAS and would theoretically allow a smooth transition. Bhasin 2009 and Dalton 2011 document the modest anabolic effect without marked suppression at 3 mg/d; at 12.5 mg/d suppression becomes clinically significant.
Dose / Duration
Ostarine 12.5 mg/d for 4-6 wk in parallel Nolvadex 20 mg/d for 4 wk. Start W+2-3 post-last AAS injection. No hCG.
Target audience
Advanced bodybuilders accepting the SARMs risk profile, prior cycles with easy HPG recovery, focus on muscle preservation. Non-standard approach.
Pros
- + Lean mass preservation during recovery
- + "Smooth" transition vs abrupt stop
- + Compatible with active post-cycle lifestyle
- + Moderate cost
- + Modest but real Ostarine anabolic effect (Dalton 2011)
Cons
- − Ostarine 12.5 mg/d moderately suppresses HPG axis — contradicts PCT goal
- − Insufficient human clinical studies
- − Black-market SARMs: highly variable quality
- − HPG recovery potentially delayed
- − Unclear legal status (research chemicals)
9. Enclomiphene 12.5 mg/d for 6 wk — the modern "pure enantiomer" PCT
Enclomiphene is the trans-enantiomer of clomiphene, separated to eliminate the estrogenic component (zuclomiphene) responsible for most side effects. Not yet widely available but emerging in modern PCT. HPG stimulation comparable to Clomid with fewer visual and mood effects. FDA status: enclomiphene was in development for male hypogonadism treatment (Androxal program).
Dose / Duration
Enclomiphene 12.5 mg/d for 4-6 wk, start post-ester clearance. Often combined with Nolvadex 20 mg/d for 4 wk.
Target audience
Advanced users with reliable enclomiphene source, sensitive to Clomid side effects (visual disturbances, mood), seeking 'modern' PCT.
Pros
- + Fewer side effects than Clomid (no zuclomiphene component)
- + Pure antiestrogenic effect
- + Short half-life (24h) — dosing flexibility
- + Emerging in modern literature
- + Improved tolerance profile
Cons
- − Still limited availability
- − High cost (~$150-250 complete cycle)
- − Long-term studies limited
- − Black market: few reliable sources
- − Not yet standard of care
10. PCT with adjuvants (DAA, ZMA, vitamins) — the complementary "natural PCT"
Nutritional adjuvants to support pharmacological PCT: D-Aspartic Acid (DAA) 3 g/d theoretically boosting LH release (controversial studies), ZMA (zinc + magnesium + B6) supporting testicular steroidogenesis, vitamin D 4000 IU/d correcting frequent deficiency, omega-3 3 g/d for post-cycle lipid profile. These adjuvants never replace Nolvadex/Clomid, but can optimize general recovery.
Dose / Duration
In complement to pharmacological PCT: DAA 3 g/d for 4 wk, daily ZMA, vitamin D 4000 IU/d, omega-3 3 g/d, NAC 1200 mg/d (liver), CoQ10 100 mg/d. During and 4-6 wk after PCT.
Target audience
Users seeking to optimize general recovery in complement to standard pharmacological PCT. Not as a replacement.
Pros
- + Accessible cost (~$30-50)
- + Excellent tolerance
- + Post-cycle lipid profile support
- + General recovery (sleep, energy)
- + Compatible with all pharmacological PCTs
Cons
- − Not a SERM substitute — adjuvant only
- − Effect on LH/T at normal doses modest to undetectable
- − Marketing often exaggerated ("natural PCT" misleading)
- − Contradictory DAA studies
- − Many pills to take

Final comparison

Protocol	HPG recovery	Suited to	Complexity	Cost
Nolva 40/40/20/20	4-8 wk	Short cycles	Very simple	$30-50
Nolva + Clomid	4-8 wk	Medium cycles	Simple	$50-80
Pre-hCG + Nolva + Clomid	6-12 wk	Long cycles/stacks	Medium	$100-150
On-cycle hCG + Nolva	4-8 wk	Long cycles (preventive)	Medium	$120-180
Clomid solo	4-8 wk	SARMs/light cycles	Very simple	$20-40
Medicalized Lipshultz PCT	6-24 months	Established ASIH	High	$600-1000
Blast & cruise	Permanent TRT	Multi-cyclists	High	$500-1500/yr
SARMs PCT	Variable	Advanced (controversial)	Medium	$80-120
Enclomiphene	4-8 wk	Clomid-sensitive	Simple	$150-250
PCT + adjuvants	+0-2 wk	Complement	Simple	$30-50 extra

FAQ

When to start PCT after the last shot?: Timing depends on ester. For testosterone propionate (half-life ~2 d): start W+3 to W+5 days after last injection. For Sustanon mix or ester blend: W+10-14 days. For testosterone enanthate/cypionate (half-life ~4-5 d): W+14-18 days. For nandrolone decanoate (half-life ~6-12 d depending on source): W+3 wk minimum. General rule: wait about 3 half-lives for serum concentration to fall below the hypothalamic negative-feedback threshold (Schulte-Beerbühl 1980, Toutain 2004). Starting too early = SERM against still-elevated serum concentration = ineffective.
Is hCG always needed in PCT?: No, depends on the cycle. For short/light cycles (Test E solo 12 wk), Nolvadex alone suffices. For long cycles (>16 wk), heavy stacks (Test + Deca/Tren), or users with laborious HPG recovery on prior cycles: pre-PCT hCG (1500-2000 IU E2D for 10 d) significantly improves recovery (Coviello 2005, Wenker 2015). hCG 'wakes up' Leydig cells before SERM start. Alternative: on-cycle hCG (250-500 IU 2x/wk from W2) to preserve testicular volume during cycle (Coviello 2005 RCT).
How long to recover natural testosterone levels?: Variable depending on several factors: cycle duration, molecules used, age, HPG genetics. Smit 2021 (HAARLEM cohort, 100 Dutch users) documents average recovery in 12-16 weeks post-PCT for moderate cycles (15 wk average), with ~70% of users returning to >85% baseline at 6 months. Long cycles with nandrolone or trenbolone: recovery often 6-9 months. Beyond 6 months without recovery = probable ASIH, endocrinologist consultation recommended (Rahnema 2014, Kanayama 2015).
What bloodwork during and after PCT?: Mid-PCT bloodwork (W+2 wk of PCT): not essential but useful if in doubt. Post-PCT bloodwork (4-6 wk after PCT end): crucial. Measure LH, FSH, total and free testosterone, ultra-sensitive E2, prolactin, SHBG. Target values at 6 wk post-PCT: LH in normal range (1.5-9 IU/L), normal FSH (1.5-12 IU/L), total testosterone >450 ng/dL ideally (norm 250-1000). If low LH and low T: incomplete recovery, wait 6 more wk then re-test. If still low at 3 months: endocrinologist consultation. Source: Anawalt 2019, Pope 2014.
Nolvadex or Clomid: which to choose?: Nolvadex (tamoxifen): better tolerance, fewer visual and mood effects, suffices for short/moderate cycles. Clomid (clomiphene): more marked HPG stimulation via GnRH effect, useful for heavier cycles, but more frequent side effects (visual disturbances per Purvin 1995, irritability, anxiety). In practice: Nolva solo for first PCT; Nolva + Clomid combo for moderate-to-heavy cycles. If known Clomid sensitivity (prior visual disturbances), switch to enclomiphene or Nolva solo dosed slightly longer.
What to do if HPG recovery fails after a well-conducted PCT?: Algorithm: (1) Confirm failure with repeat bloodwork at 3 months post-PCT (low LH + low T). (2) Eliminate confounders (vitamin D deficiency, hyperthyroidism, obesity, medications). (3) Attempt repeat PCT with pre-PCT hCG + Clomid 25 mg/d for 8-12 wk (Lipshultz protocol, Rahnema 2014). (4) If failure at 6 cumulative months: ASIH diagnosis, urologist/endocrinologist consultation. (5) Options: long-term Clomid continuation (Katz 2012, Ramasamy 2014), or switch to medicalized TRT based on preference and desired fertility. Reference framework: Bhasin 2018 (Endocrine Society Guideline).
Can hCG alone replace a classic PCT?: No. hCG mimics endogenous LH and directly stimulates Leydig cells, but it does not wake up the hypothalamic HPG axis. An hCG-only PCT will leave the user dependent on hCG to produce testosterone, without restoring hypothalamic-pituitary feedback. hCG is useful in pre-PCT (Leydig wake-up) or on-cycle (testicular preservation), but must be followed by a SERM (Nolva/Clomid) which restores GnRH-LH-FSH pulsatility. Liu 2002 (hCG meta-analysis spermatogenesis induction) confirms this logic.
What effects on libido and mood during PCT?: Sensitive period. Exogenous testosterone stops covering the user (progressive ester clearance), while endogenous testosterone is not yet restored — hence 'PCT depression': libido drop, fatigue, anxiety, irritability, sleep disturbances. Transient phenomenon in most (3-8 wk), resolved with natural testosterone restoration. Support strategies: sleep >=8h, maintained moderate exercise, stable nutrition, vitamin D + ZMA supplementation. If mood degraded >12 wk, medical consultation (Piacentino 2015, Kanayama 2009 on AAS dependence and withdrawal symptoms).

Best PCT (post-cycle therapy) protocols in 2026 — 10 schemes ranked

Methodology

1. Nolvadex 40/40/20/20 for 4 wk — the standard PCT for short cycles

The reference protocol for short/light cycles (Test E solo 12-14 wk at 400-500 mg/wk, or solo SARMs cycles). Tamoxifen (Nolvadex) blocks hypothalamic estrogen receptors, lifting negative feedback and allowing LH and FSH resumption (Vermeulen 1978, Jordan 1993). Excellent tolerance, few side effects compared to Clomid.

Dose / Duration

Tamoxifen: 40 mg/d for 2 wk, then 20 mg/d for 2 wk. Start: W+2 to W+3 after last injection (for long ester), or W+3 days (short ester). Total duration: 4 wk.

Target audience

First Test E solo 400-500 mg/wk for 12 wk cycles, solo SARMs cycles, users with demonstrated HPG recovery on prior cycles.

Pros

+ Simple, mono-molecule protocol, few side effects
+ Well-documented efficacy (Vermeulen 1978, Jordan 1993)
+ Accessible cost (~$30-50 for complete PCT)
+ Excellent overall tolerance vs Clomid
+ Wide pharmacy and UGL availability

Cons

− Insufficient for long cycles (>16 wk) or heavy stacks
− No direct effect on Leydig cells
− Hot flashes, transient libido drop
− Risk of ocular effects at very high doses (Purvin 1995: risk on Clomid > Nolvadex)
− Biphasic effect on IGF-1

2. Nolvadex + Clomid (40/40/20/20 + 50/50/25/25) for 4 wk — the classic medium-cycle PCT

The standard for medium cycles (Test E 500 mg/wk ± oral, 12-14 wk). The Nolvadex + Clomid combo attacks estrogenic negative feedback on two fronts: tamoxifen for hot flashes and residual gynecomastia, clomiphene to more aggressively stimulate hypothalamic GnRH release (Katz 2012, Whitten 2006). Faster HPG recovery according to Rahnema 2014.

Dose / Duration

Tamoxifen: 40 mg/d for 2 wk, then 20 mg/d for 2 wk. Clomiphene: 50 mg/d for 2 wk, then 25 mg/d for 2 wk. Start same timing as Nolva solo. Duration: 4 wk.

Target audience

Medium 12-14 wk cycles with moderate Test E (400-500 mg/wk) ± oral kickstart, users already familiar with PCT, seeking faster HPG recovery.

Pros

+ Synergy of two SERMs on HPG axis
+ Faster HPG recovery vs Nolva solo (Rahnema 2014)
+ Empirically validated by 30 years of use
+ Moderate cost (~$50-80)
+ Good overall tolerance

Cons

− Clomid side effects: visual disturbances ("flickering"), mood changes (Purvin 1995)
− Protocol cumbersome (4 doses/d)
− No direct action on Leydig cells
− Insufficient for very long cycles or deca/tren stacks
− Compliance harder than Nolva solo

3. Pre-PCT hCG + Nolvadex + Clomid — the long-cycles/heavy-stacks PCT

Advanced protocol for long cycles (>16 wk) or stacks with deca/tren. Phase 1: hCG 1500-2000 IU E2D for 10 days to 'wake up' Leydig cells after prolonged suppression (Coviello 2005, Wenker 2015). Phase 2: standard Nolvadex + Clomid for 4 wk. hCG mimics endogenous LH and allows testicular steroidogenesis restart before SERM kickoff.

Dose / Duration

Phase 1 hCG: 1500-2000 IU E2D for 10 days (W+3 days post-last short ester injection, W+2 wk post-long ester). Phase 2 SERM: Nolvadex 40/40/20/20 + Clomid 50/50/25/25 for 4 wk, starting 3 days after last hCG injection.

Target audience

Long cycles (>16 wk), stacks with nandrolone decanoate or trenbolone enanthate, advanced users (3rd cycle+), laborious HPG recovery on prior cycles.

Pros

+ Documented testicular wake-up (Coviello 2005, Wenker 2015)
+ Faster and more complete HPG recovery post-long cycles
+ Suited to deep suppressions (deca, tren, prolonged blast)
+ Reduces ASIH risk (Rahnema 2014)
+ Allows restart even after suppression > 4 months

Cons

− Higher cost (~$100-150 complete PCT)
− Logistical burden (hCG injections + 4 oral doses/d)
− Leydig desensitization risk if hCG poorly dosed or prolonged
− E2 may increase under hCG (mini-aromatization) — AI to titrate
− Black market: highly variable hCG quality

4. On-cycle hCG + Nolvadex PCT — the "testicular preservation" strategy

Preventive strategy: maintain an LH-like signal during the cycle via low-dose hCG (250-500 IU 2x/wk), to preserve testicular volume and Leydig function. Coviello 2005 (RCT) demonstrates that 250 IU hCG E2D maintains intratesticular testosterone at -7% vs -57% under testosterone alone. Allows simpler post-cycle PCT (Nolvadex alone suffices).

Dose / Duration

On-cycle: hCG 250-500 IU 2x/wk (from W2 of cycle). hCG stop: 1-2 wk before cycle end. PCT: Nolvadex 40/40/20/20 for 4 wk, start W+2-3 post-last injection.

Target audience

Users having done prior cycles with slow HPG recovery, users on long or repeated cycles, seeking preserved long-term fertility.

Pros

+ Testicular volume preserved during cycle
+ Simplified post-cycle PCT (Nolva solo suffices)
+ Faster HPG recovery
+ Psychological comfort (visibly non-atrophied testicles)
+ Solid scientific reference (Coviello 2005)

Cons

− hCG engagement throughout entire cycle duration
− Additional cost during cycle
− If hCG too high: Leydig desensitization + E2 increase
− Logistics of additional injections
− Black market: variable hCG quality (Magnolini 2022)

5. Clomid solo 50/50/25/25 for 4 wk — the SARMs/light-cycles PCT

Minimalist PCT for SARMs cycles (Ostarine, light RAD140) or very light AAS cycles (short solo Test E 300 mg/wk). Clomid at 50 mg/d for 2 wk then 25 mg/d for 2 wk strongly stimulates GnRH release. Studies in young hypogonadal men (Katz 2012, Whitten 2006) document effective elevation of LH/FSH and testosterone.

Dose / Duration

Clomiphene: 50 mg/d for 2 wk, then 25 mg/d for 2 wk. Variable start depending on ester or SARM type. Duration: 4 wk.

Target audience

SARMs cycles (Ostarine 25 mg/d for 8 wk, RAD140 10 mg/d for 8 wk), very light AAS cycles (Test E 300 mg/wk for 8-10 wk), first PCT experiences.

Pros

+ Marked HPG stimulation via GnRH effect
+ Documented efficacy in hypogonadal men (Katz 2012)
+ Very accessible cost (~$20-40)
+ Sufficient for light cycles
+ Wide availability (pharmacy and UGL)

Cons

− Visual effects (Purvin 1995: "flickering", blurred vision) in 5-10% of users
− Mood changes (irritability, anxiety)
− Insufficient for moderate/heavy AAS cycles
− No direct action on Leydig cells
− Pro-estrogenic effect long term at high doses

6. Medicalized "Lipshultz" PCT — the supervised restart

Protocol inspired by American urological literature (Lipshultz, Crosnoe, Kovac, Kim) for users who failed a classic PCT or present with ASIH (anabolic steroid-induced hypogonadism). Combines hCG, low-dose long-term Clomid, sometimes pure enclomiphene, and monthly biological monitoring for 6 months. Rahnema 2014 and Crosnoe 2013 document this scheme.

Dose / Duration

hCG 1500 IU 2x/wk for 4 wk, then Clomid 25 mg/d continuous for 12-24 wk with monthly LH/FSH/T monitoring. Adaptations based on response. Endocrinologist/urologist supervision.

Target audience

Users with confirmed ASIH (testosterone <250 ng/dL + low LH 3 months post-classic PCT), willingness for natural recovery vs TRT, available medical access.

Pros

+ Medical supervision guarantees individual case adaptation
+ Validated by urological literature (Rahnema 2014, Crosnoe 2013)
+ Alternative to TRT in young ASIH user
+ Continuous monitoring allows precise adjustments
+ Allows HPG recovery in difficult cases

Cons

− High cost (consultations + bloodwork + medication ~$600-1000)
− Long commitment (6-24 months)
− Medical access not always simple
− Clomid side effects long term
− Not suited to standard post-cycle PCT

7. Blast & cruise "PCT" — transition to permanent TRT

No longer a PCT in the strict sense, but an alternative strategy for multi-cycle users who have exhausted natural recovery options. Switch to medically supervised TRT at physiological dose (testosterone 100-150 mg/wk) with maintenance hCG (500 IU 2x/wk). Bhasin 2018 (Endocrine Society Guideline) frames TRT indications. Bridging between cycles, no more classic PCT.

Dose / Duration

Cruise: Testosterone enanthate 100-150 mg/wk continuous + hCG 500 IU 2x/wk. Bloodwork every 3 months (total/free T, E2, hematocrit, lipids, PSA). Periodic blast 500 mg/wk for 8-12 wk.

Target audience

Users having done 6+ cycles, established ASIH, informed choice of permanent TRT, short-term fertility not prioritized, accessible medical supervision.

Pros

+ Avoids stop-restart cycles and cumulative ASIH risk
+ Hormonal and psychological stability
+ Medical supervision possible (legal TRT)
+ Maintenance of muscle gains between blasts
+ Bhasin 2018 frames medical indications

Cons

− Permanent dependence on exogenous testosterone
− Non-negligible annual cost (~$500-1500 depending on supervision)
− Reduced fertility (mitigated by hCG)
− Long-term cardiovascular effect to monitor (Lincoff 2023 TRAVERSE)
− Not suitable if immediate fertility desired

8. SARMs "PCT" — restart with Ostarine in transition

Controversial strategy: use a low-dose SARM (Ostarine 12.5 mg/d) in post-cycle transition to preserve muscle mass during HPG recovery under SERM. Ostarine is less suppressive than AAS and would theoretically allow a smooth transition. Bhasin 2009 and Dalton 2011 document the modest anabolic effect without marked suppression at 3 mg/d; at 12.5 mg/d suppression becomes clinically significant.

Dose / Duration

Ostarine 12.5 mg/d for 4-6 wk in parallel Nolvadex 20 mg/d for 4 wk. Start W+2-3 post-last AAS injection. No hCG.

Target audience

Advanced bodybuilders accepting the SARMs risk profile, prior cycles with easy HPG recovery, focus on muscle preservation. Non-standard approach.

Pros

+ Lean mass preservation during recovery
+ "Smooth" transition vs abrupt stop
+ Compatible with active post-cycle lifestyle
+ Moderate cost
+ Modest but real Ostarine anabolic effect (Dalton 2011)

Cons

− Ostarine 12.5 mg/d moderately suppresses HPG axis — contradicts PCT goal
− Insufficient human clinical studies
− Black-market SARMs: highly variable quality
− HPG recovery potentially delayed
− Unclear legal status (research chemicals)

9. Enclomiphene 12.5 mg/d for 6 wk — the modern "pure enantiomer" PCT

Enclomiphene is the trans-enantiomer of clomiphene, separated to eliminate the estrogenic component (zuclomiphene) responsible for most side effects. Not yet widely available but emerging in modern PCT. HPG stimulation comparable to Clomid with fewer visual and mood effects. FDA status: enclomiphene was in development for male hypogonadism treatment (Androxal program).

Dose / Duration

Enclomiphene 12.5 mg/d for 4-6 wk, start post-ester clearance. Often combined with Nolvadex 20 mg/d for 4 wk.

Target audience

Advanced users with reliable enclomiphene source, sensitive to Clomid side effects (visual disturbances, mood), seeking 'modern' PCT.

Pros

+ Fewer side effects than Clomid (no zuclomiphene component)
+ Pure antiestrogenic effect
+ Short half-life (24h) — dosing flexibility
+ Emerging in modern literature
+ Improved tolerance profile

Cons

− Still limited availability
− High cost (~$150-250 complete cycle)
− Long-term studies limited
− Black market: few reliable sources
− Not yet standard of care

10. PCT with adjuvants (DAA, ZMA, vitamins) — the complementary "natural PCT"

Nutritional adjuvants to support pharmacological PCT: D-Aspartic Acid (DAA) 3 g/d theoretically boosting LH release (controversial studies), ZMA (zinc + magnesium + B6) supporting testicular steroidogenesis, vitamin D 4000 IU/d correcting frequent deficiency, omega-3 3 g/d for post-cycle lipid profile. These adjuvants never replace Nolvadex/Clomid, but can optimize general recovery.

Dose / Duration

In complement to pharmacological PCT: DAA 3 g/d for 4 wk, daily ZMA, vitamin D 4000 IU/d, omega-3 3 g/d, NAC 1200 mg/d (liver), CoQ10 100 mg/d. During and 4-6 wk after PCT.

Target audience

Users seeking to optimize general recovery in complement to standard pharmacological PCT. Not as a replacement.

Pros

+ Accessible cost (~$30-50)
+ Excellent tolerance
+ Post-cycle lipid profile support
+ General recovery (sleep, energy)
+ Compatible with all pharmacological PCTs

Cons

− Not a SERM substitute — adjuvant only
− Effect on LH/T at normal doses modest to undetectable
− Marketing often exaggerated ("natural PCT" misleading)
− Contradictory DAA studies
− Many pills to take

Final comparison

Protocol	HPG recovery	Suited to	Complexity	Cost
Nolva 40/40/20/20	4-8 wk	Short cycles	Very simple	$30-50
Nolva + Clomid	4-8 wk	Medium cycles	Simple	$50-80
Pre-hCG + Nolva + Clomid	6-12 wk	Long cycles/stacks	Medium	$100-150
On-cycle hCG + Nolva	4-8 wk	Long cycles (preventive)	Medium	$120-180
Clomid solo	4-8 wk	SARMs/light cycles	Very simple	$20-40
Medicalized Lipshultz PCT	6-24 months	Established ASIH	High	$600-1000
Blast & cruise	Permanent TRT	Multi-cyclists	High	$500-1500/yr
SARMs PCT	Variable	Advanced (controversial)	Medium	$80-120
Enclomiphene	4-8 wk	Clomid-sensitive	Simple	$150-250
PCT + adjuvants	+0-2 wk	Complement	Simple	$30-50 extra

FAQ

When to start PCT after the last shot?: Timing depends on ester. For testosterone propionate (half-life ~2 d): start W+3 to W+5 days after last injection. For Sustanon mix or ester blend: W+10-14 days. For testosterone enanthate/cypionate (half-life ~4-5 d): W+14-18 days. For nandrolone decanoate (half-life ~6-12 d depending on source): W+3 wk minimum. General rule: wait about 3 half-lives for serum concentration to fall below the hypothalamic negative-feedback threshold (Schulte-Beerbühl 1980, Toutain 2004). Starting too early = SERM against still-elevated serum concentration = ineffective.
Is hCG always needed in PCT?: No, depends on the cycle. For short/light cycles (Test E solo 12 wk), Nolvadex alone suffices. For long cycles (>16 wk), heavy stacks (Test + Deca/Tren), or users with laborious HPG recovery on prior cycles: pre-PCT hCG (1500-2000 IU E2D for 10 d) significantly improves recovery (Coviello 2005, Wenker 2015). hCG 'wakes up' Leydig cells before SERM start. Alternative: on-cycle hCG (250-500 IU 2x/wk from W2) to preserve testicular volume during cycle (Coviello 2005 RCT).
How long to recover natural testosterone levels?: Variable depending on several factors: cycle duration, molecules used, age, HPG genetics. Smit 2021 (HAARLEM cohort, 100 Dutch users) documents average recovery in 12-16 weeks post-PCT for moderate cycles (15 wk average), with ~70% of users returning to >85% baseline at 6 months. Long cycles with nandrolone or trenbolone: recovery often 6-9 months. Beyond 6 months without recovery = probable ASIH, endocrinologist consultation recommended (Rahnema 2014, Kanayama 2015).
What bloodwork during and after PCT?: Mid-PCT bloodwork (W+2 wk of PCT): not essential but useful if in doubt. Post-PCT bloodwork (4-6 wk after PCT end): crucial. Measure LH, FSH, total and free testosterone, ultra-sensitive E2, prolactin, SHBG. Target values at 6 wk post-PCT: LH in normal range (1.5-9 IU/L), normal FSH (1.5-12 IU/L), total testosterone >450 ng/dL ideally (norm 250-1000). If low LH and low T: incomplete recovery, wait 6 more wk then re-test. If still low at 3 months: endocrinologist consultation. Source: Anawalt 2019, Pope 2014.
Nolvadex or Clomid: which to choose?: Nolvadex (tamoxifen): better tolerance, fewer visual and mood effects, suffices for short/moderate cycles. Clomid (clomiphene): more marked HPG stimulation via GnRH effect, useful for heavier cycles, but more frequent side effects (visual disturbances per Purvin 1995, irritability, anxiety). In practice: Nolva solo for first PCT; Nolva + Clomid combo for moderate-to-heavy cycles. If known Clomid sensitivity (prior visual disturbances), switch to enclomiphene or Nolva solo dosed slightly longer.
What to do if HPG recovery fails after a well-conducted PCT?: Algorithm: (1) Confirm failure with repeat bloodwork at 3 months post-PCT (low LH + low T). (2) Eliminate confounders (vitamin D deficiency, hyperthyroidism, obesity, medications). (3) Attempt repeat PCT with pre-PCT hCG + Clomid 25 mg/d for 8-12 wk (Lipshultz protocol, Rahnema 2014). (4) If failure at 6 cumulative months: ASIH diagnosis, urologist/endocrinologist consultation. (5) Options: long-term Clomid continuation (Katz 2012, Ramasamy 2014), or switch to medicalized TRT based on preference and desired fertility. Reference framework: Bhasin 2018 (Endocrine Society Guideline).
Can hCG alone replace a classic PCT?: No. hCG mimics endogenous LH and directly stimulates Leydig cells, but it does not wake up the hypothalamic HPG axis. An hCG-only PCT will leave the user dependent on hCG to produce testosterone, without restoring hypothalamic-pituitary feedback. hCG is useful in pre-PCT (Leydig wake-up) or on-cycle (testicular preservation), but must be followed by a SERM (Nolva/Clomid) which restores GnRH-LH-FSH pulsatility. Liu 2002 (hCG meta-analysis spermatogenesis induction) confirms this logic.
What effects on libido and mood during PCT?: Sensitive period. Exogenous testosterone stops covering the user (progressive ester clearance), while endogenous testosterone is not yet restored — hence 'PCT depression': libido drop, fatigue, anxiety, irritability, sleep disturbances. Transient phenomenon in most (3-8 wk), resolved with natural testosterone restoration. Support strategies: sleep >=8h, maintained moderate exercise, stable nutrition, vitamin D + ZMA supplementation. If mood degraded >12 wk, medical consultation (Piacentino 2015, Kanayama 2009 on AAS dependence and withdrawal symptoms).